Omada hits 275K cumulative users. More on Pear, Limbix, ATX.

Issue 020.

Get E&O weekly. | Subscribe | Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a 64 percent open rate. Here's what's happening this week:

I'll be at the DTxEast event in Boston next week, and I'm excited about the lineup. Let me know if you'll be there.
Missed this last week: Trialcard acquired medication adherence startup Mango Health. When Mango's founder and CEO Jason Oberfest left to join Apple's health team in December, it was a fair assumption that the company was looking for a buyer.
Germany-based digital therapeutics company Kaia raised $8 million in a round led by UnitedHealth Group's Optum Ventures. Kaia offers programs that address back pain and COPD. The company says it has enrolled 275,000 people into its programs. It just raised a $10M round in January led by Balderton Capital.
Sequoia-based digital therapeutics company

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Omada hits 275K cumulative users. More on Pear, Limbix, ATX.

Welcome to E&O.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.